US SB1038 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 29 2023 - 25% progression, died in committee
Action: 2023-03-29 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 29 2023 - 25% progression, died in committee
Action: 2023-03-29 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.
Title
Drug Price Transparency in Medicaid Act of 2023
Sponsors
| Sen. Peter Welch [D-VT] | Sen. Roger Marshall [R-KS] | Sen. Shelley Capito [R-WV] | Sen. Kirsten Gillibrand [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-03-29 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB1613 (Same As) 2023-03-24 - Referred to the Subcommittee on Health.
HB3561 (Related) 2024-12-17 - Referred to the Subcommittee on Health.
HB3561 (Related) 2024-12-17 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1038/all-info |
| Text | https://www.congress.gov/118/bills/s1038/BILLS-118s1038is.pdf |
